Search

everythinglearnresearchcommunity

for

Search:↓

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

Abrocitinib may effectively treat stubborn alopecia universalis.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.

Personalized treatment plans are important for people with alopecia areata.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Vitiligo and alopecia areata may share common causes.

Alopecia areata negatively affects the self-esteem and quality of life of children and teens.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

People with alopecia areata may have a higher risk of hearing loss.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Alopecia Areata is an autoimmune disease causing hair loss in patches, often starting before age 20, and while some cases recover on their own, treatments include topical corticosteroids, minoxidil, and promising new methods like IL-31 antibodies and 308-nm Excimer laser therapy.

The monkey's hair loss was due to an autoimmune disease, not genetics.

Steroid pulse therapy improved symptoms in a man with Satoyoshi syndrome.

A new CNN model can detect Alopecia Areata with 98% accuracy.

Platelet-Rich Plasma (PRP) could potentially help regrow hair in people with Alopecia Areata, but more research is needed to confirm its effectiveness.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

People with Down syndrome have a higher risk of autoimmune diseases, so early detection and care are important.

New therapies for alopecia areata show potential but need more research.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Topical prostaglandin E2 can help treat both alopecia areata and vitiligo.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.